Study Seeks to Discover Markers Identifying Patients Who Can Safely Avoid Prostate Cancer Treatment

Dr. Daniel Lin, Professor at the University of Washington, Department of Urology, shares his pioneering research in concert with the Canary Foundation after over a decade of research and over 2,000 patients. Their research encompasses the largest multi-site surveillance study with a biorepository in North America.

Click HERE to learn more about his extensive research in early detection of prostate cancer and what the future holds for patients across the globe.